 |
Simone Buitendijk is Professor of Women’s and Family Health University of Leiden. She received her MD at University of Utrecht, MPH at Yale in the US, and PhD at Leiden University. Dr. Buitendijk’s primary scholarship is in maternal and child health, with a focus on midwifery studies and perinatal epidemiology. She researches issues in maternity care in the Netherlands, such as the degree of satisfaction of Dutch women with their pregnancy and birth care, the trend in referrals from midwife to obstetrician and the safety of the system of birth. She co-authored a large nationwide study of neonatal outcomes of home births.
|
|
|
Lelia Duley is an Obstetric Epidemiologist with over 20 years experience in randomised trials and systematic reviews. Having worked in Oxford and then Leeds, in March 2011 she took up the post as Director of the Nottingham Clinical Trials Unit. She is also Editor with the Cochrane Pregnancy and Childbirth Group.
|
|
|
K.S Joseph MD, PhD is a Professor in the Departments of Obstetrics and Gynaecology and the School of Population and Public Health, University of British Columbia, Vancouver, Canada. His interests include pregnancy complications, preterm birth, fetal growth and infant mortality/morbidity. He is a member of the Editorial board of Paediatric and Perinatal Epidemiology and BMC Pregnancy and Childbirth and the Co-Chair of the Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System (organization responsible for perinatal surveillance in Canada).
|
|
|
Dr Shoo K. Lee is a neonatologist and health economist. He is a professor of paediatrics, obstetrics and gynecology and public health, and head of the division of neonatology at the University of Toronto; paediatrician-in-chief and director of the Maternal-Infant Care (MICare) Research Centre at Mt. Sinai Hospital; chief of the department of newborn and developmental paediatrics at Sunnybrook Health Sciences Centre; and the women's auxiliary chair in neonatology and head of the division of neonatology at the Hospital for Sick Children. He established the Canadian Neonatal Network and the International Neonatal Collaboration to foster collaborative research and leads the CIHR Team in Maternal- Infant care. His research focuses on improving quality of care, patient outcomes and health care services delivery.
|
 |
Dr Shahirose Premji is an associate professor in the Faculty Nursing at the University of Calgary. She completed a post-doctoral fellowship at the University of Calgary (2000-2001). She received her PhD in Clinical Health Sciences (Nursing) from McMaster University in 2000. Dr Premji has completed a Canadian Health Services Research Foundation/Canadian Institute of Health Research Nursing Research Internship in Multiple Interventions for Community Health Nursing from the University of Ottawa. Her program of research relates to vulnerable population with a global health perspective. Her specific areas of research interest include examining socio-cultural influences on infant health and survival; examining the role of psychosocial factors as both risk factors and targets of intervention to prevent adverse consequences of pregnancy; early intervention to promote growth and development of vulnerable infants. Dr. Premji has worked in Canada, Australia, Tanzania and China, and is actively involved in with the International Relations Committee for National Association of Neonatal Nurses and the Council of International Neonatal Nurses. She also took a 2-year leave of absence from University of Calgary to work with the Aga Khan University – School of Nursing in Karachi, Pakistan. |
|
Associate Professor David Walker is part of The Ritchie Centre’s Fetal, Neonatal and Child Health group. Associate Professor Walker is a physiologist with a long interest in fetal and neonatal development. Over the last five years his research has become centred on perinatal brain damage and the cause of cerebral palsy.
David in an expert in studies examining factor that increase oxidative damage following hypoxia/ischemia in late gestation. His work focuses on the development of new neuroprotective agents for reducing perinatal brain injury. He is also particularly interested in protecting and improving myelination and reducing PVL.
|